BioCentury | Aug 29, 2005
Company News

Prima, Austin Research Institute deal

...subsidiaries (see BioCentury, Aug.15). PRR now owns all shares of Oncomab Pty Ltd., Panvax Ltd., Cancer Vac...
BioCentury | Aug 15, 2005
Company News

Prima BioMed, Austin Research Institute deal

...close to a 10% share in PRR. The subsidiaries are Oncomab Pty Ltd., Panvax Ltd., Cancer Vac...
...proposed to acquire all other shares in Arthron and outstanding options issued by Panvax and Cancer Vac...
BioCentury | Oct 13, 2003
Company News

Prima, Progen Industries deal

...PGL will manufacture PRR subsidiary Cancer Vac's dendritic cell cancer vaccine for use in a Phase II...
BioCentury | Jul 21, 2003
Clinical News

Cancer vaccine: Phase Ib

...PRR's Cancer Vac subsidiary reported that 2 patients from a Phase Ib trial have continued therapy for...
BioCentury | Oct 28, 2002
Clinical News

Cancer vaccine: Phase I

...in 10 patients showed that all patients given the vaccine had tumor-specific immune responses. PRR's Cancer Vac Ltd....
BioCentury | May 13, 2002
Clinical News

Cancer vaccine: Phase I

...showed that all 8 patients who have completed treatment showed tumor specific immune responses. PRR's Cancer Vac Ltd....
Items per page:
1 - 6 of 6
BioCentury | Aug 29, 2005
Company News

Prima, Austin Research Institute deal

...subsidiaries (see BioCentury, Aug.15). PRR now owns all shares of Oncomab Pty Ltd., Panvax Ltd., Cancer Vac...
BioCentury | Aug 15, 2005
Company News

Prima BioMed, Austin Research Institute deal

...close to a 10% share in PRR. The subsidiaries are Oncomab Pty Ltd., Panvax Ltd., Cancer Vac...
...proposed to acquire all other shares in Arthron and outstanding options issued by Panvax and Cancer Vac...
BioCentury | Oct 13, 2003
Company News

Prima, Progen Industries deal

...PGL will manufacture PRR subsidiary Cancer Vac's dendritic cell cancer vaccine for use in a Phase II...
BioCentury | Jul 21, 2003
Clinical News

Cancer vaccine: Phase Ib

...PRR's Cancer Vac subsidiary reported that 2 patients from a Phase Ib trial have continued therapy for...
BioCentury | Oct 28, 2002
Clinical News

Cancer vaccine: Phase I

...in 10 patients showed that all patients given the vaccine had tumor-specific immune responses. PRR's Cancer Vac Ltd....
BioCentury | May 13, 2002
Clinical News

Cancer vaccine: Phase I

...showed that all 8 patients who have completed treatment showed tumor specific immune responses. PRR's Cancer Vac Ltd....
Items per page:
1 - 6 of 6